Aclarion (ACON) Stock Forecast — 2-Week Outlook

StockMap's current 2-week read on Aclarion (ACON) is Moderate Underperform.

The composite score behind that read is -0.45, weighing +0.00 of bullish evidence against -0.45 bearish.

Aclarion last closed at $2.29, -2.14% on the session.

Against the IVW growth benchmark the position is -2.75% over the forecast window.

The read is built from 12 underlying insights — 0 bullish and 12 bearish.

Agreement across those insights is 100%.

17 graded predictions for ACON so far. We publish our accuracy across thousands of stocks in the open, misses included — no per-stock hit rate is claimed on a small sample.

On the fundamentals StockMap ranks Aclarion in the 16th percentile on return on equity, where 100 is best.

Aclarion is classified under Health Care / Health Care Technology, with a market capitalisation of $6.74M.

StockMap tracks Aclarion as the 19th largest of the 19 companies it covers in the Health Care Technology industry, part of the Health Care sector.

Across that group the current two-week reads are 12 Neutral and 7 Moderate Underperform.

On that composite Aclarion ranks 19th of 19 in the group, against a group median of -0.15.